Literature DB >> 15692256

Fibrin stabilization (factor XIII), fibrin structure and thrombosis.

Zsuzsanna Bereczky1, Eva Katona, László Muszbek.   

Abstract

Factor XIII (FXIII) is a zymogen that is converted into an active transglutaminase (FXIIIa) by the concerted action of thrombin and Ca2+. Its main task is to crosslink alpha-, and gamma-chains of fibrin and alpha2-plasmin inhibitor to fibrin. By this way FXIIIa strengthens fibrin and protects it from the prompt elimination by fibrinolytic system.The changes of FXIII level in thrombotic diseases are hardly explored and there are contradictory results concerning the protective effect of Val34Leu polymorphism against arterial or venous thrombosis. The results suggest that the thrombo-protective effect of Leu34 allele prevails only in certain genetic and/or environmental constellations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15692256     DOI: 10.1159/000083841

Source DB:  PubMed          Journal:  Pathophysiol Haemost Thromb        ISSN: 1424-8832


  8 in total

1.  Indwelling catheters and medical implants with FXIIIa inhibitors: A novel approach to the treatment of catheter and medical device-related infections.

Authors:  Nooshin Daneshpour; Russell Collighan; Yvonne Perrie; Peter Lambert; Dan Rathbone; Deborah Lowry; Martin Griffin
Journal:  Eur J Pharm Biopharm       Date:  2012-09-25       Impact factor: 5.571

Review 2.  Genetic predictors of response to photodynamictherapy.

Authors:  Francesco Parmeggiani; Donato Gemmati; Ciro Costagliola; Francesco Semeraro; Paolo Perri; Sergio D'Angelo; Mario R Romano; Katia De Nadai; Adolfo Sebastiani; Carlo Incorvaia
Journal:  Mol Diagn Ther       Date:  2011-08-01       Impact factor: 4.074

3.  Factor XIIIA-V34L and factor XIIIB-H95R gene variants: effects on survival in myocardial infarction patients.

Authors:  Donato Gemmati; Federica Federici; Gianluca Campo; Silvia Tognazzo; Maria L Serino; Monica De Mattei; Marco Valgimigli; Patrizia Malagutti; Gabriele Guardigli; Paolo Ferraresi; Francesco Bernardi; Roberto Ferrari; Gian L Scapoli; Linda Catozzi
Journal:  Mol Med       Date:  2007 Jan-Feb       Impact factor: 6.354

4.  Concentration independent modulation of local micromechanics in a fibrin gel.

Authors:  Maxwell A Kotlarchyk; Samir G Shreim; Martha B Alvarez-Elizondo; Laura C Estrada; Rahul Singh; Lorenzo Valdevit; Ekaterina Kniazeva; Enrico Gratton; Andrew J Putnam; Elliot L Botvinick
Journal:  PLoS One       Date:  2011-05-23       Impact factor: 3.240

5.  Network screening of Goto-Kakizaki rat liver microarray data during diabetic progression.

Authors:  Huarong Zhou; Shigeru Saito; Guanying Piao; Zhi-Ping Liu; Jiguang Wang; Katsuhisa Horimoto; Luonan Chen
Journal:  BMC Syst Biol       Date:  2011-06-20

6.  Simultaneous activation of complement and coagulation by MBL-associated serine protease 2.

Authors:  Anders Krarup; Russell Wallis; Julia S Presanis; Péter Gál; Robert B Sim
Journal:  PLoS One       Date:  2007-07-18       Impact factor: 3.240

7.  Effect of Factor XIII-A G185T Polymorphism on Visual Prognosis after Photodynamic Therapy for Neovascular Macular Degeneration.

Authors:  Francesco Parmeggiani; Ciro Costagliola; Francesco Semeraro; Mario R Romano; Michele Rinaldi; Carla Enrica Gallenga; Maria Luisa Serino; Carlo Incorvaia; Sergio D'Angelo; Katia De Nadai; Roberto Dell'Omo; Andrea Russo; Donato Gemmati; Paolo Perri
Journal:  Int J Mol Sci       Date:  2015-08-20       Impact factor: 5.923

8.  Proteomic Analysis of Renal Biomarkers of Kidney Allograft Fibrosis-A Study in Renal Transplant Patients.

Authors:  Line Aas Mortensen; Anne Marie Svane; Mark Burton; Claus Bistrup; Helle Charlotte Thiesson; Niels Marcussen; Hans Christian Beck
Journal:  Int J Mol Sci       Date:  2020-03-30       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.